← FDA DRUG APPROVALS

FDA ANDA · ANDA210232

POMALIDOMIDE

Sponsor: SUN PHARMACEUTICAL INDUSTRIES LIMITED

APPLICATION
ANDA210232
TYPE
ANDA
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)

Products

POMALIDOMIDENone (Tentative Approval)
POMALIDOMIDE 1MG · CAPSULE
POMALIDOMIDENone (Tentative Approval)
POMALIDOMIDE 4MG · CAPSULE
POMALIDOMIDENone (Tentative Approval)
POMALIDOMIDE 2MG · CAPSULE
POMALIDOMIDENone (Tentative Approval)
POMALIDOMIDE 3MG · CAPSULE

Approval history

2026-03-24UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →